Is GHRP-2 legal? FDA status and US regulatory standing
Current status
Barred from compounding. GHRP-2 is not FDA-approved and has been placed in a category of bulk substances that licensed pharmacies may not compound (status recorded ).
Primary source: www.fda.gov
Federal legal status
FDA approval status
GHRP-2 is not FDA-approved and has been placed in a category of bulk substances that licensed pharmacies may not compound. Approved for diagnostic GH stimulation testing in Japan (Kaken Pharma) but NOT FDA-approved. Not on FDA 503A Category 1 or Category 2 list. WADA prohibited. Research chemical in US.
Also known as
Growth Hormone Releasing Peptide 2 · Pralmorelin · GHRP2
Status history
- GHRP-2 is not FDA-approved and has been placed in a category of bulk substances that licensed pharmacies may not compound. [source]
Frequently asked questions
- Is GHRP-2 FDA approved?
- GHRP-2 is not FDA-approved and has been placed in a category of bulk substances that licensed pharmacies may not compound (status recorded 2023-09-29). Primary source linked on this page.
- Is GHRP-2 legal to buy?
- GHRP-2 is available in the U.S. as a research-use-only compound. It is not FDA-approved and has been placed in a category of bulk substances that licensed pharmacies may not compound. Sale for human consumption is not permitted.
Content review: Regulatory status is sourced from the linked primary records and reviewed by the PeptideBase editorial team. This page is educational — not legal or medical advice. Last reviewed: .